Patients-reported desirable features and outcomes in migrain...
📅 2026년 5월 18일📰 Br J Pain👀 조회 1
최근 학술지에 게재된 연구에 따르면, Understanding patient preferences for migraine treatments is essential for patient-centered care and for informing the development and optimization of therapeutic options. Although individual preference-elicitation studies exist, evidence has not 연구진은 관찰 연구를 통해 We conducted a scoping review in accordance with PRISMA 2020 guidelines. PubMed, Scopus, Web of Science, and Google Scholar were searched for peer-reviewed studies that elicited patient preferences 그 결과, 20 studies comprising 6435 participants were included. Across preventive and acute treatment contexts, efficacy-related outcomes were consistently prioritized by patients. For preventive treatments, key valued attributes included reduction in migraine frequency, durability of effect, tolerability, and convenience, with preferences varying by prior treatment experience and disease severity. Fo 연구팀은 "Patient preferences for migraine treatments are multifactorial and vary across treatment goals, modalities, and patient subgroups. While methodological limitations across studies constrain definitive conclusions, this review highlights consistent "라고 결론지었다. 이번 연구의 의의는 해당 분야에 새로운 통찰을 제공했다. 다만 연구진은 장기적 효과는 추가 연구가 필요하다고 밝혔다.
A recent study published in a peer-reviewed journal reveals that Understanding patient preferences for migraine treatments is essential for patient-centered care and for informing the development and optimization of therapeutic options. Although individual preference-elicitation studies exist, evidence has not The researchers conducted an observational study to investigate We conducted a scoping review in accordance with PRISMA 2020 guidelines. PubMed, Scopus, Web of Science, and Google Scholar were searched for peer-reviewed studies that elicited patient preferences Results showed that 20 studies comprising 6435 participants were included. Across preventive and acute treatment contexts, efficacy-related outcomes were consistently prioritized by patients. For preventive treatments, key valued attributes included reduction in migraine frequency, durability of effect, tolerability, and convenience, with preferences varying by prior treatment experience and disease severity. Fo The authors concluded, "Patient preferences for migraine treatments are multifactorial and vary across treatment goals, modalities, and patient subgroups. While methodological limitations across studies constrain definitive conclusions, this review highlights consistent " This study is significant as it provides new insights in the field. However, the researchers noted that long-term effects require further investigation.
